A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies.

about

Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma.

P2860

Q54941716-BFFC32F4-2F24-4311-915B-83B44070F32A

P2860

A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies.

Item

http://www.wikidata.org/entity/Q50145911

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

A Review of New Findings in Ad ...... Emerging Treatment Strategies.

@en

A Review of New Findings in Ad ...... Emerging Treatment Strategies.

@nl

type

Item

label

A Review of New Findings in Ad ...... Emerging Treatment Strategies.

@en

A Review of New Findings in Ad ...... Emerging Treatment Strategies.

@nl

prefLabel

A Review of New Findings in Ad ...... Emerging Treatment Strategies.

@en

A Review of New Findings in Ad ...... Emerging Treatment Strategies.

@nl

P1476

A Review of New Findings in Ad ...... Emerging Treatment Strategies.

@en

P2093

Juan Carlos Ramos

http://www.w3.org/2001/XMLSchema#string

Kensei Tobinai

http://www.w3.org/2001/XMLSchema#string

Olivier Hermine

http://www.w3.org/2001/XMLSchema#string

P2860

Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.

VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.

Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study

Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.

Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.

Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.

Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study.

Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphoma.

P2888

s12325-018-0658-4

P304

135-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-018-0658-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29411267

http://www.w3.org/2001/XMLSchema#string

P932

5818559

http://www.w3.org/2001/XMLSchema#string

A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies.

about

P2860

P2860

A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932